A Discussion on Antibody Development and Engineering With Twist Biopharma

A Discussion on Antibody Development and Engineering With Twist Biopharma

Stephen Riffle
Drug Development

Twist Biopharma is a division of Twist Bioscience with a mission to solve some of the world’s most intractable health challenges through next-generation drug development. In the three short years since Twist Biopharma’s launch, it’s formed more than 20 partnerships that have now led to 25 active programs that range in application from oncology to veterinary medicine. 

And, there’s likely many more to come as the Twist Biopharma team continues to build out its services. 

Twist Biopharma Product Manager Melina Mathur, Ph.D., recently spoke about Twist Biopharma’s services, partnerships, and future in therapeutic discovery with Lu Rahman of the Drug Discovery World podcast.  

Read highlights from their conversation on Twist’s blog, Writing the Future.

Using Massively Parallel Reporter Assays (MPRAs) to elucidate the function of genetic variation

Using Massively Parallel Reporter Assays (MPRAs) to elucidate the function of genetic variation
Single-cell multi-omics sheds light on the importance of tissue heterogeneity

Single-cell multi-omics sheds light on the importance of tissue heterogeneity